The market is experiencing a growing preference for fully automated analyzers, for the multitude of benefits they offer – convenience, flexibility in operations, less turn-around time, improved performance and quality, and increased profitability. However, laboratories are under increasing pressure for better clinical outcomes and to contain costs. In order to cater to these demands, manufacturers are incorporating certain advanced features such as static photometry technology, low reagent consumption, permanent hard glass cuvettes that are cost effective, on-board cooling, on-board laundry etc. that add to the efficiency of a fully automated analyzer.

Wilmington, January, 2020: Axiom Market Research & Consulting™ added a report on global benchtop clinical chemistry analyzer market which includes study on various product, type, test and end user across various countries of key regions across the globe. The global veterinary pain management market was projected to grow at a CAGR of 5.66% for the forecast period 2020 to 2026. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the benchtop clinical chemistry analyzer market.  

The report analyses the global benchtop clinical chemistry analyzer market based on product, type, test, end user and geography. Various products studied in this report are analyzers reagents & consumables and other products. The reagents and consumables include calibrators, controls, standards and other reagents & consumables. Commercially available bench top analyzers are accessible in various sizes including small (Less than 200 Test/H), medium (200-400 Tests/H) and large (More than 400 Tests/H) analyzers. The bench top benchtop clinical chemistry analyzer devices presented as semi-automated and fully automated analyzers. These are used to carry out number of tests including basic metabolic panel test, electrolyte panels test, liver panel test, lipid profile test, renal profiles test, thyroid function panel test and specialty chemicals. The major end users of the market are hospitals, commercial laboratories, academic institutes and other end users. 

The North American region dominated the global benchtop clinical chemistry analyzer market in 2019

North America seems to be promising region for benchtop clinical chemistry analyzer market. The North America region occupied around 49% of share of the global benchtop clinical chemistry analyzer market. Advanced healthcare infrastructure and high disposable income in this region is expected to majorly drive the benchtop clinical chemistry analyzer market during the forecast period.

Additionally, Asia-Pacific region is predicted to be the fastest growing region in the global benchtop clinical chemistry analyzer market. Rapidly growing demand for better healthcare and government policies which are focusing on the healthcare sector is propelling the demand of benchtop clinical chemistry analyzer in Asia-Pacific region.

The reagents & consumables segment dominated the global benchtop clinical chemistry analyzer Market in 2019

The substantial share reagents & consumables is predicted to be a consequence of wide array of reagents present in the market, catering to different requirements. In addition, reagents are believed to be highly cost efficient, possess optimum sensitivity, linearity, and precision, which thereby, ensures minimized performance variation. 

The automated benchtop clinical chemistry analyzer accounted for the largest market share of 59% in 2019

Fully automated benchtop clinical chemistry analyzer segment dominated the market owing to various properties such as intelligent multitasking software, perfect self-checking function, automatic calibration, automatic washing, maximum throughput, with onboard cooling and advanced technology.

Basic Metabolic Panel (BMP) accounted for the largest market share in 2019 

BMP comprises a set of tests that provide clinical information pertaining to problems caused by chemical imbalance in the body to the medical examiners. The associated benefits with this test have resulted in high acceptance of the same, thereby widening the segment share over the years.

The commercial laboratories segment accounted for the largest market share of 49% in 2019 

The growth of commercial laboratories segment is attributed by various drives such as several major technological advances, scientific achievement combined with growing prevalence of various lifestyle disease diagnosis in clinical laboratories.  

The major companies operating in the benchtop clinical chemistry analyzer market include AGD Biomedicals Pvt. Ltd., AMS Alliance, Balio Diagnostics, Beckman Coulter (Subsidiary of Danaher Corporation), Biochemical Systems International S.p.A., DiaSys Diagnostic Systems GmbH, EKF Diagnostics, Elitech Group, F. Hoffmann-La Roche Ltd., Horiba, Ltd., Medica Corporation, Meril Life Sciences Pvt. Ltd., Mindray Medical International Limited, Randox Laboratories Ltd., Siemens AG, Thermo Fisher Scientific Inc., and Wiener lab Group.  

Key Takeaways from the report:

• The reagents & consumables segment dominated the global benchtop clinical chemistry analyzer Market in 2019
• The automated benchtop clinical chemistry analyzer accounted for the largest market share of 59.63% in 2019, owing to various properties such as intelligent multitasking software, perfect self-checking function, automatic calibration, automatic washing, maximum throughput and advanced technology.
• Rising importance of and awareness regarding point-of-care testing is also one of the key contributing factors toward the basic metabolic panel segment share, which accounted for 29% in 2019
• The commercial laboratories segment dominated the global benchtop clinical chemistry analyzer market, by end user in 2019